Enhanced efficacy of combined temozolomide and bromodomain inhibitor therapy for gliomas using targeted nanoparticles

Fred C. Lam, Paula T. Hammond(Broad Institute), Jeffrey Wyckoff(Integrative Medicine Institute), Amanda Maffa(Massachusetts Institute of Technology), Michael B. Yaffe(Beth Israel Deaconess Medical Center), Mun Kyung Hwang(Massachusetts Institute of Technology), Tu-Lan Vu Han(Massachusetts Institute of Technology), Scott Floyd(Duke University), Stephen W. Morton(Massachusetts Institute of Technology), Elena Balkanska-Sinclair(University of Massachusetts Chan Medical School)
Nature Communications
May 14, 2018
Cited by 328


Related Papers